Literature DB >> 16234354

Phagocytosis of codeveloping megakaryocytic progenitors by dendritic cells in culture with thrombopoietin and tumor necrosis factor-alpha and its possible role in hemophagocytic syndrome.

Kunie Saito1, Makoto Hirokawa, Kayo Inaba, Hiroshi Fukaya, Yoshinari Kawabata, Atsushi Komatsuda, Junsuke Yamashita, Kenichi Sawada.   

Abstract

Tumor necrosis factor-alpha (TNF-alpha) and thrombopoietin (TPO) have been shown to induce the differentiation and proliferation of CD34+ cells toward dendritic cells (DCs) in the presence of multiacting cytokines. We hypothesized that the costimulation of TPO and TNF-alpha generates megakaryocytic progenitors and DCs together from human CD34+ cells and that the interaction of these cells may indicate a physiologic and/or a pathologic role of DCs in megakaryopoiesis. When highly purified human CD34+ cells were cultured for 7 days with TPO alone, the generated cells expressed megakaryocytic markers, such as CD41, CD42b, and CD61. The addition of TNF-alpha with TPO remarkably decreased the number of megakaryocytic progenitor cells without affecting the cell yield. Almost half of the cells thus generated expressed CD11c, and most of them were positive for CD4 and CD123. Furthermore, CD11c+ cells were found to capture damaged CD61+ cells and to induce autologous T-cell proliferation, although the cytokine productions were low. We also confirmed an engulfment of CD61+ cells and their fragment by CD11c+ cells in bone marrow cells from patients with hemophagocytic syndrome. These findings suggest that DCs generated under megakaryocytic and inflammatory stimuli are involved in megakaryopoiesis and the subsequent immune responses to self-antigens.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16234354     DOI: 10.1182/blood-2005-08-3155

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  CpG-ODN 2006 and human parvovirus B19 genome consensus sequences selectively inhibit growth and development of erythroid progenitor cells.

Authors:  Yong-Mei Guo; Keiko Ishii; Makoto Hirokawa; Hiroyuki Tagawa; Hideaki Ohyagi; Yoshihiro Michishita; Kumi Ubukawa; Junsuke Yamashita; Toshiaki Ohteki; Nobuyuki Onai; Kazuyoshi Kawakami; Weiguo Xiao; Kenichi Sawada
Journal:  Blood       Date:  2010-03-26       Impact factor: 22.113

2.  Enucleation of human erythroblasts involves non-muscle myosin IIB.

Authors:  Kumi Ubukawa; Yong-Mei Guo; Masayuki Takahashi; Makoto Hirokawa; Yoshihiro Michishita; Miho Nara; Hiroyuki Tagawa; Naoto Takahashi; Atsushi Komatsuda; Wataru Nunomura; Yuichi Takakuwa; Kenichi Sawada
Journal:  Blood       Date:  2011-11-02       Impact factor: 22.113

3.  Infection of bone marrow cells by dengue virus in vivo.

Authors:  Sansanee Noisakran; Nattawat Onlamoon; Hui-Mien Hsiao; Kristina B Clark; Francois Villinger; Aftab A Ansari; Guey Chuen Perng
Journal:  Exp Hematol       Date:  2011-12-19       Impact factor: 3.084

4.  Delayed addition of tumor necrosis factor (TNF) antagonists inhibits the generation of CD11c+ dendritic cells derived from CD34+ cells exposed to TNF-alpha.

Authors:  Yong-Mei Guo; Makoto Hirokawa; Naoto Takahashi; Masumi Fujishima; Naohito Fujishima; Atsushi Komatsuda; Hiroyuki Tagawa; Hideaki Ohyagi; Yoshihiro Michishita; Kumi Ubukawa; Miwa Hebiguchi; Weiguo Xiao; Kenichi Sawada
Journal:  Int J Hematol       Date:  2009-12-12       Impact factor: 2.490

5.  Dynamics of human erythroblast enucleation.

Authors:  Miwa Hebiguchi; Makoto Hirokawa; Yong-Mei Guo; Kunie Saito; Hideki Wakui; Atsushi Komatsuda; Naohito Fujishima; Naoto Takahashi; Tsutomu Takahashi; Takehiko Sasaki; Wataru Nunomura; Yuichi Takakuwa; Kenichi Sawada
Journal:  Int J Hematol       Date:  2008-12-02       Impact factor: 2.490

6.  Phagocytosis of co-developing neutrophil progenitors by dendritic cells in a culture of human CD34(+) cells with granulocyte colony-stimulating factor and tumor necrosis factor-alpha.

Authors:  Yoshinobu Saito; Yong Mei Guo; Makoto Hirokawa; Kunie Saito; Atsushi Komatsuda; Naoto Takahashi; Masumi Fujishima; Naohito Fujishima; Junsuke Yamashita; Kenichi Sawada
Journal:  Int J Hematol       Date:  2008-05-20       Impact factor: 2.490

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.